Startup Evvy raises $40M to accelerate precision diagnostics and medicine for women’s health
$40M. Evvy just closed its Series B to scale AI-powered women's health diagnostics — betting precision medicine is the wedge into a fragmented market.
Why it matters
A healthcare AI startup raises meaningful capital to scale a diagnostics platform. Practitioners in healthtech and VCs tracking AI-in-medicine will note the round size and investor mix; enthusiasts tracking AI funding velocity see another data point in the biotech/diagnostics boom.
The key facts
8 to knowSeries B round: $40M
Lead investor: Catalio Capital Management
New investors: U.S. Fertility Innovation Fund, Rethink Impact, Muse Capital, Alumni Ventures
Focus: AI-powered precision diagnostics and care platform for women's health
Announced: September 15, 2026
Series B: $40M
Focus: AI precision diagnostics and care platform for women's health
Date: September 15, 2026
Go to the source
SiliconAnglesiliconangle.com
Publisher excerpt: Evvy, an artificial intelligence startup that’s looking to enhance women’s healthcare, said today it has closed on $40 million in Series B funding to scale its precision diagnostics and care platform. The round was led by Catalio Capital Management, with new investors including the U.S. Fertility…